Insider Trading & Ownership - Goeltz II Robert C.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Goeltz II Robert C.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-02
Sale
2024-01-04
5:23 pm
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
2,004$20$40,08051,831
(Direct)
View
2023-06-07
Sale
2023-06-09
4:05 pm
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
4,049$20.04$81,14259,392
(Direct)
View
2022-12-16
Sale
2022-12-16
9:44 pm
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
2,453$30.75$75,43011,566
(Direct)
View
2021-12-16
Sale
2021-12-20
4:22 pm
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
1,106$40.12$44,3767,019
(Direct)
View
2020-09-09
Purchase
2020-09-09
4:53 pm
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
5,000$21.57$107,8495,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-23
Option Award(A)
2024-02-23
5:49 pm
N/A
N/A
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
22,000$073,831
(Direct)
View
2024-01-23
Option Award
2024-01-25
7:40 pm
N/A
2034-01-22
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
107,900$0159,731
(Direct)
View
2023-12-19
Disposition
2023-12-20
4:10 pm
N/A
N/A
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
2,808$18.0953,835
(Direct)
View
2023-12-18
Disposition
2023-12-20
4:10 pm
N/A
N/A
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
2,749$17.7453,835
(Direct)
View
2023-01-23
Option Award
2023-01-25
5:53 pm
N/A
2033-01-22
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
172,200$0201,641
(Direct)
View
2022-03-08
Option Award
2022-03-10
5:08 pm
N/A
2032-03-07
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
78,000$085,019
(Direct)
View
2021-01-19
Option Award
2021-01-20
4:10 pm
N/A
2031-01-18
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
87,500$092,500
(Direct)
View
2020-08-03
Option Award
2020-08-04
6:53 pm
N/A
2030-07-31
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
250,000$0250,000
(Direct)
View

Ownership
2020-08-04
6:15 pm
N/A
N/A
Arcus Biosciences Inc.RCUSGoeltz II Robert C.
Chief Financial Officer
0$00
(Direct)
View
2020-06-22
Tax Withholding
2020-06-24
5:03 pm
N/A
N/A
Unity Biotechnology Inc.UBXGoeltz II Robert C.
Chief Financial Officer
2,483$9.67161,027
(Direct)
View
2020-03-30
Option Award
2020-04-01
5:16 pm
N/A
2030-03-29
Unity Biotechnology Inc.UBXGoeltz II Robert C.
Chief Financial Officer
147,294$0281,698
(Direct)
View
2020-02-24
Exercise
2020-02-26
5:48 pm
N/A
N/A
Unity Biotechnology Inc.UBXGoeltz II Robert C.
Chief Financial Officer
10,000$3.43245,024
(Direct)
View
2020-02-24
Exercise
2020-02-26
5:48 pm
N/A
2027-09-26
Unity Biotechnology Inc.UBXGoeltz II Robert C.
Chief Financial Officer
10,000$0245,024
(Direct)
View
(A) Indicate amendment filing.